Semaglutide: Wegovy weight loss drug set for use on NHS also cuts heart attack and stroke risk, trial shows

A weight-loss jab which could be available on the NHS by the end of the year can also reduce the risk of a heart attack or stroke by 20 per cent, according  Read More